Drug therapy: Sorafenib
Richard S. Finn – 22 April 2010
Richard S. Finn – 22 April 2010
James E. Everhart, Kiran M. Bambha – 22 April 2010
Li Fu, Sui‐Sui Dong, Yi‐Wu Xie, Lai‐Shan Tai, Leilei Chen, Kar Lok Kong, Kwan Man, Dan Xie, Yan Li, Yingduan Cheng, Qian Tao, Xin‐Yuan Guan – 22 April 2010 – Loss of 16q is one of the most frequent alterations in many malignancies including hepatocellular carcinomas (HCC), suggesting the existence of a tumor suppressor gene (TSG) within the frequently deleted region. In this report we describe the identification and characterization of one candidate TSG, tyrosine aminotransferase gene (TAT), at 16q22.1.
Kari N. Nejak‐Bowen, Michael D. Thompson, Sucha Singh, William C. Bowen, Mohd Jamal Dar, Jaspal Khillan, Chunsun Dai, Satdarshan P.S. Monga – 22 April 2010 – The Wnt/β‐catenin pathway is implicated in the pathogenesis of hepatocellular cancer (HCC). We developed a transgenic mouse (TG) in the FVB strain that overexpresses Ser45‐mutated‐β‐catenin in hepatocytes to study the effects on liver regeneration and cancer. In the two independent TG lines adult mice show elevated β‐catenin at hepatocyte membrane with no increase in the Wnt pathway targets cyclin‐D1 or glutamine synthetase.
Wataru Ito, Shigeharu Ueki, Masahide Takeda, Tomomi Tanigai, Hiroyuki Kayaba, Junichi Chihara – 22 April 2010
Weihong Hou, Qing Tian, Jianyu Zheng, Herbert L. Bonkovsky – 22 April 2010 – Hepatitis C virus (HCV) directly induces oxidative stress and liver injury. Bach1, a basic leucine zipper mammalian transcriptional repressor, negatively regulates heme oxygenase 1 (HMOX1), a key cytoprotective enzyme that has antioxidant and anti‐inflammatory activities. microRNAs (miRNAs) are small noncoding RNAs (≈22 nt) that are important regulators of gene expression. Whether and how miRNAs regulate Bach1 or HCV are largely unknown.
Ryan M. Gill, Linda D. Ferrell – 22 April 2010
Adam P. Levene, Hiromi Kudo, Mark R. Thursz, Quentin M. Anstee, Robert D. Goldin – 22 April 2010
Hanning You, Wei Ding, C. Bart Rountree – 22 April 2010 – Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem cells and cancer stem cells in various tissues including liver. CD133 expression has been recently linked to poor prognosis in HCC patients. CD133+ liver cancer cells are characterized by resistance to chemotherapy, self‐renewal, multilineage potential, increased colony formation, and in vivo cancer initiation at limited dilution.
Anne Davit‐Spraul, Monique Fabre, Sophie Branchereau, Christiane Baussan, Emmanuel Gonzales, Bruno Stieger, Olivier Bernard, Emmanuel Jacquemin – 22 April 2010 – Progressive familial intrahepatic cholestasis (PFIC) types 1 and 2 are characterized by normal serum gamma‐glutamyl transferase (GGT) activity and are due to mutations in ATP8B1 (encoding FIC1) and ABCB11 (encoding bile salt export pump [BSEP]), respectively. Our goal was to evaluate the features that may distinguish PFIC1 from PFIC2 and ease their diagnosis.